1654
S. Jarosz, S. Sko´ra / Tetrahedron: Asymmetry 12 (2001) 1651–1656
tri-benzyloxy-6,7-ene-9-[(1%S)-5,5-dimethyl-2,4-dioxol-
ane-1%-yl]}decalin 6 was prepared according to Ref. 5.
at room temperature and partitioned between brine and
ethyl acetate. The product was isolated by column
chromatography (hexane:ethyl acetate, 1:6); yield of 9
121 mg (74%); HRMS [ESI] m/z: 627.2997
[C36H44O8Na (M+Na+) requires 627. 2928]. Anal. calcd
for C36H44O8: C, 71.50; H, 7.33. Found: C, 71.23; H,
7.40%.
4.2. Functionalization of the carbonyl group in 6
4.2.1. (1R,2S,3S,4R,5S,9S,10R)-{1-Hydroxy-2,3,4-tri-
benzyloxy-6,7-ene-9-[(1%S)-5,5-dimethyl-2,4-dioxolane-1%-
yl]}decalin 7. Ketone 6 (150 mg, 0.26 mmol) was
dissolved in MeOH (6 mL), THF (5 mL) and water (3
mL) and the mixture treated with sodium borohydride
(15 mg, 1.5 equiv.) and stirred at room temperature for
30 min. The mixture was concentrated, the crude
product was extracted with ethyl acetate and purified
by column chromatography (hexane:ethyl acetate, 5:1)
to afford 7 as an oil (140 mg, 93%). HRMS m/z:
593.2928 [C36H42O6Na (M+Na+) requires 593.2874].
Anal. calcd for C36H42O6: C, 75.76; H, 7.42. Found: C,
75.52; H, 7.22%.
This compound was further characterized as its tri-
acetate derivative: [h]D=−13.7; 1H NMR l: 5.71 (J5,6
ꢀ
3 Hz, H-6), 5.04 (ddd, J6,7 3.1, J7,8 4.5, J7,8a 12.1, H-7),
4.93 (dd, J1,10 3.9, J1,2 10.8, H-1), 4.61 (m, H-1%), 3.81
(dd, J2,3 9.0, H-2), 3.73 (m, H-4, 2%,2%a), 3.59 (dd, J3,4
8.8, H-3), 2.22 (m, H-9), 2.08 (m, H-5,8,10), 2.08, 1.98
and 1.94 (3×CH3CO2), 1.53 (m, H-8a), 1.44 and 1.34
[C(CH3)2]; 13C NMR l: 170.0, 169.6 and 169.4 (3×
CꢀO), 108.6 [C(CH3)2], 87.2, 78.7, 78.0, 74.4, 74.3, 68.7,
67.6 (C-1,2,3,4,6,7,1%), 75.7, 75.5 and 75.2 (3×CH2Ph),
63.9 (C-2%), 44.4, 36.5 and 35.7 (C-5,9,10), 25.9 and 24.5
[C(CH3)2], 24.7 (C-8), 21.2, 21.0 and 20.9 (3×CH3CO2).
Compound 7 was further characterized as its acetate
derivative. [h]D=+91.5; 1H NMR l: 5.89 (m, H-6), 5.71
(m, H-7), 5.05 (dd, J1,10 3.5, J1,2 8.7, H-1), 4.35 (m,
H-1%), 3.87 (dd, J1%,2% 6.6, J2%,2%a 8.2, H-2%), 3.85 (dd, J2,3
8.3, H-2), 3.65 (dd, J3,4 9.4, H-3), 3.60 (dd, J1%,2%a 6.5,
H-2%a), 3.57 (t, J4,5 9.4, H-4), 2.41 (m, H-5), 2.21 and
1.76 (2×m, both H-8), 2.15 (m, H-9 and H-10), 1.96
(CH3CO2), 1.43 and 1.33 [C(CH3)2]; 13C NMR l: 169.9
(CꢀO), 128.1 (C-6), 126.4 (C-7), 108.5 [C(CH3)2], 86.5
(C-3), 83.7 (C-4), 80.4 (C-2), 76.2 (C-1%), 75.5, 75.3 and
74.2 (3×CH2Ph), 75.3 (C-1), 65.9 (C-2%), 39.4 (C-5), 37.5
and 36.0 (C-9,10), 26.3 and 24.9 [C(CH3)2], 25.8 (C-8),
21.3 (CH3CO2).
4.4. Epoxidation reaction of unsaturated decalins
4.4.1. Reaction of 7 with m-chloroperbenzoic acid. To a
solution of olefin 7 (770 mg, 1.35 mmol) in methylene
chloride (30 mL) was added MCPBA (500 mg, 85%
purity, 2.7 mmol) and the mixture was kept at room
temperature for 24 h. Ether (100 mL) was added, the
organic layer was washed with 0.5% NaOH, water,
dried, concentrated, and the products 10 (330 mg, 42%)
and 11 (350 mg, 44%) were isolated by column chro-
matography (hexane:ethyl acetate, 4:12:1).
4.4.1.1. (1R,2S,3S,4R,5R,6S,7R,9S,10R)-{6,7-Anhy-
dro-1-hydroxy-2,3,4-tri-benzyl oxy-9-[(1%S)-5,5-dimethyl-
2,4-dioxolane-1%-yl]}decalin 10. HRMS m/z: 609.2827
[C36H42O7Na (M+Na+) requires 609.2823]. Anal. calcd
for C36H42O7: C, 73.70; H, 7.22. Found: C, 73.51; H,
7.28%. [h]D=+68.4; 1H NMR l: 4.24 (dd, J1%,2% 6.3,
H-1%), 3.97 (dd, J2%,2%a 8.5, H-2%), 3.69–3.57 (m, H-
2,3,4,2%a), 3.54 (m, H-1), 3.49 (d, J1,OH 5.8, OH), 3.44
(dd, J5,6 2.6, J6,7 4.0, H-6), 2.92 (t, J6,7=J7,8 4.0, H-7),
2.28 (ddd, J4.5 11.0, J5.10 4.0, H-5), 2.01 (m, H-10), 1.91
(m, H-8), 1.85 (m, H-9), 1.61 (m, H-8a), 1.40 and 1.32
[C(CH3)2]. 13C NMR l: 108.8 [C(CH3)2], 87.3, 87.1,
79.2, 77.3 and 74.4 (C-1,2,3,4,1%), 75.8, 75.3 and 75.1
(3×CH2Ph), 66.9 (C-2%), 53.6 and 51.0 (C-6,7), 39.2,
36.9 and 33.2 (C-5,9,10), 26.3 and 25.3 [C(CH3)2], 24.3
(C-8). NOE: H5-H6 (5.3%).
4.2.2. (1R,2S,3S,4R,5S,9S,10R)-{1-2,3,4-Tetra-benzyl-
oxy-6,7-ene-9-[(1%S)-5,5-dimethyl-2,4-dioxolane-1%-yl]}-
decalin 8. Benzylation (BnBr, NaH, DMF) of alcohol 7
afforded 90% of 8 which was isolated as an oil by
column chromatography (hexane:ethyl acetate, 8:1);
1
[h]D=+87.8; H NMR l: 5.89 (m, H-6), 5.75 (m, H-7),
4.77 (m, H-1%), 3.87 (dd, J1,2 9.6, J2,3 8.6, H-2), 3.76 (dd,
J1%,2% 7.1, J2%,2%a 8.6, H-2%), 3.62 (dd, J1%,2%a 5.4, H-2%), 3.57
(m, H-3,4), 3.53 (dd, J1,10 4.3, H-1), 2.32 (m, H-8), 2.22
(m, H-5, H-9), 1.95 (ddd, J9,10 11.2, J5,10 4.8, H-10),
1.81 (m, H-8a), 1.41 and 1.25 [C(CH3)2]; 13C NMR l:
128.3–127.3 (C-6,7 and C arom.), 107.9 [C(CH3)2], 86.8,
84.6, 82.9, 82.1 and 75.7 (C-1,2,3,4,1%), 75.6, 75.5, 75.3
and 74.4 (4×CH2Ph), 65.0 (C-2%), 40.4, 39.4 and 35.2
(C-5,9,10), 26.0 and 24.2 [C(CH3)2], 25.8 (C-8). Anal.
calcd for C43H48O6: C, 78.15; H, 7.32. Found: C, 78.10;
H, 7.43%.
4.4.1.2. (1R,2S,3S,4R,5R,6R,7S,9S,10R)-{6,7-Anhy-
dro-1-hydroxy-2,3,4-tri-benzyl oxy-9-[(1%S)-5,5-dimethyl-
2,4-dioxolane-1%-yl]}decalin 11. HRMS m/z: 609.2828
[C36H42O7Na (M+Na+) requires 609.2823]. Anal. calcd
for C36H42O7: C, 73.70; H, 7.22. Found: C, 73.80; H,
4.3. cis-Hydroxylation of 7:
(1R,2S,3S,4R,5R,6S,7R,9S,10R)-{1,6,7-tri-hydroxy-
2,3,4-tri-benzyloxy-9-[(1%S)-5,5-dimethyl-2,4-dioxolane-
1%-yl]}decalin 9
1
7.42%. [h]D=+35.8; H NMR l: 4.14 (m, H-1%), 4.04
(dd, J1%,2% 5.7, J2%,2%a 8.4, H-2%), 3.97 (d, J1,OH 7.8, OH),
3.89 (dd, J4,5 9.9, J3,4 10.2, H-4), 3.67 (m, H-1,2), 3.58
(m, H-3,2%a), 3.42 (dd, J5,6 5.1, J6,7 4.0, H-6), 3.34 (m,
H-7), 2.27 (m, H-5), 2.09 (m, H-8), 1.81 (m, H-9,10),
1.46 (m, H-8a), 1.39 and 1.35 [C(CH3)2]; 13C NMR l:
109.2 [C(CH3)2], 86.5, 81.5 (double intensity), 79.9, and
77.8 (C-1,2,3,4,1%), 67.9 (C-2%), 53.3 and 53.2 (C-6,7),
Olefin 7 (155 mg, 0.26 mmol) was dissolved in THF (5
mL), tert-butanol (0.2 mL) and water (0.05 mL) to
which N-methyl morpholine N-oxide (80 mg) and
osmium tetraoxide (0.2 mL of a ca. 2% solution in
toluene) were added. The mixture was stirred for 24 h